Literature DB >> 9536321

The strategy for the treatment of osteoporosis.

C Christiansen1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9536321     DOI: 10.1007/bf03194361

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


× No keyword cloud information.
  24 in total

1.  Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group.

Authors:  J A Kanis
Journal:  Osteoporos Int       Date:  1994-11       Impact factor: 4.507

2.  Postmenopausal bone loss is prevented by treatment with low-dosage estrogen with calcium.

Authors:  B Ettinger; H K Genant; C E Cann
Journal:  Ann Intern Med       Date:  1987-01       Impact factor: 25.391

3.  Dose-response evaluation of cyclic estrogen/gestagen in postmenopausal women: placebo-controlled trial of its gynecologic and metabolic actions.

Authors:  M S Christensen; C Hagen; C Christiansen; I Transbøl
Journal:  Am J Obstet Gynecol       Date:  1982-12-15       Impact factor: 8.661

4.  Estrogen therapy arrests bone loss in elderly women.

Authors:  M E Quigley; P L Martin; A M Burnier; P Brooks
Journal:  Am J Obstet Gynecol       Date:  1987-06       Impact factor: 8.661

5.  Long-term estrogen replacement therapy prevents bone loss and fractures.

Authors:  B Ettinger; H K Genant; C E Cann
Journal:  Ann Intern Med       Date:  1985-03       Impact factor: 25.391

6.  17 Beta-estradiol and continuous norethisterone: a unique treatment for established osteoporosis in elderly women.

Authors:  C Christiansen; B J Riis
Journal:  J Clin Endocrinol Metab       Date:  1990-10       Impact factor: 5.958

7.  Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group.

Authors:  U A Liberman; S R Weiss; J Bröll; H W Minne; H Quan; N H Bell; J Rodriguez-Portales; R W Downs; J Dequeker; M Favus
Journal:  N Engl J Med       Date:  1995-11-30       Impact factor: 91.245

8.  Prevention of bone mineral loss in postmenopausal women by norethisterone.

Authors:  H I Abdalla; D M Hart; R Lindsay; I Leggate; A Hooke
Journal:  Obstet Gynecol       Date:  1985-12       Impact factor: 7.661

9.  Effect of external hip protectors on hip fractures.

Authors:  J B Lauritzen; M M Petersen; B Lund
Journal:  Lancet       Date:  1993-01-02       Impact factor: 79.321

10.  Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study.

Authors:  T L Bush; E Barrett-Connor; L D Cowan; M H Criqui; R B Wallace; C M Suchindran; H A Tyroler; B M Rifkind
Journal:  Circulation       Date:  1987-06       Impact factor: 29.690

View more
  1 in total

1.  Osteoporosis Update 1997. Symposium proceedings. Osaka, Japan, 13-16 November 1997.

Authors: 
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.